top of page

CLINICAL TRIALS​

International CIPN Assessment and Validation Study (ICAVS)

NCT04633655

PATENTS

Tumor Agnostic Drug Delivery with Self-Agglomerating Nanohydrogels

Housley et al. 

Application No. PCT/US2024/040745

Combination Therapeutics for Treatment of Proliferative Disorders

Housley et al. 

Application No. 18/271,926

Inline Manipulation of Cells and Cell Clusters

Boya et al. 

Application No. PCT/US2023/082980

Start Ups

OnCuRNA

At OnCuRNA, our novel nanohydrogel system (SANGs) enhances the delivery of therapeutic payloads to solid tumors, offering unprecedented control over drug release, targeting, and efficacy.

Have Questions?

Shoot us an email! We love to talk science. 

Powered and secured by Wix

bottom of page